144558-44-1 Usage
Description
3-(4-BROMO-2-THIENYL)ACRYLIC ACID is a chemical compound characterized by the molecular formula C8H5BrO2S. It is a carboxylic acid derivative featuring a bromine atom and a thienyl group attached to an acrylic acid moiety. This yellow solid is sparingly soluble in water and exhibits a distinctive odor. As an intermediate in chemical synthesis and research, it plays a significant role in the creation of various organic compounds.
Uses
Used in Pharmaceutical Industry:
3-(4-BROMO-2-THIENYL)ACRYLIC ACID is utilized as a key intermediate in the synthesis of pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 3-(4-BROMO-2-THIENYL)ACRYLIC ACID serves as an essential component in the production of various agrochemicals. Its properties contribute to the formulation of effective products for agricultural use.
Used in Chemical Synthesis and Research:
3-(4-BROMO-2-THIENYL)ACRYLIC ACID is employed as an intermediate in the synthesis of a wide range of organic compounds. Its presence in chemical reactions facilitates the creation of new molecules with diverse applications.
It is crucial to handle 3-(4-BROMO-2-THIENYL)ACRYLIC ACID with appropriate care and adhere to safety guidelines to mitigate any potential hazards associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 144558-44-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,4,5,5 and 8 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 144558-44:
(8*1)+(7*4)+(6*4)+(5*5)+(4*5)+(3*8)+(2*4)+(1*4)=141
141 % 10 = 1
So 144558-44-1 is a valid CAS Registry Number.
144558-44-1Relevant articles and documents
PROPENAMIDE THIOPHENE DERIVATIVES AS FLAVIVIRUS INHIBITORS AND THEIR USE
-
Page/Page column 19; 20; 21, (2017/07/06)
The present invention deals with new flavivirus inhibitors, compositions comprising said inhibitors and methods for the treatment of disorders related to a viral infection, such as a disease due to a flavivirus infection, comprising administering said inhibitors.